M. Ambrosini

发表

Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity.

J. Garcia-Vallejo, Y. van Kooyk, Sjoerd T. T. Schetters, 2020, Biomaterials.

Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.

G. Storm, J. Garcia-Vallejo, Y. van Kooyk, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1

T. D. de Gruijl, G. Storm, Y. van Kooyk, 2021, Vaccines.

Enhanced glycan nanoprofiling by weak anion exchange preparative chromatography, mild acid desialylation, and nanoliquid chromatography‐mass spectrometry with nanofluorescence detection

Y. Kooyk, J. Garcia-Vallejo, M. Ambrosini, 2013, Electrophoresis.

Langerin-mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross-presentation by human Langerhans cells

Y. Kooyk, J. Garcia-Vallejo, S. Bruijns, 2015, Cellular and Molecular Immunology.

Polyvalent C-glycomimetics based on l-fucose or d-mannose as potent DC-SIGN antagonists.

J. Rojo, F. Fieschi, R. Ribeiro-Viana, 2017, Organic & biomolecular chemistry.

Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets

T. D. de Gruijl, J. Garcia-Vallejo, Y. van Kooyk, 2019, Theranostics.

In situ Delivery of Antigen to DC-SIGN(+)CD14(+) Dermal Dendritic Cells Results in Enhanced CD8(+) T-Cell Responses.

Y. Kooyk, T. D. de Gruijl, G. Storm, 2015, The Journal of investigative dermatology.

Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+ T‐cell cross‐priming

Y. Kooyk, E. Hooijberg, S. Bruijns, 2014, European journal of immunology.

Comparison of intradermal injection and epicutaneous laser microporation for antitumor vaccine delivery in a human skin explant model

Y. van Kooyk, M. Ambrosini, H. Kalay, 2019, bioRxiv.

Liposome induction of CD8+ T cell responses depends on CD169+ macrophages and Batf3-dependent dendritic cells and is enhanced by GM3 inclusion.

G. Storm, P. Crocker, K. Asano, 2021, Journal of controlled release : official journal of the Controlled Release Society.

Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.

T. D. de Gruijl, G. Storm, K. Nazmi, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells

R. Nieuwland, T. Würdinger, S. Dusoswa, 2019, Journal of extracellular vesicles.

α2-3 Sialic acid binding and uptake by human monocyte-derived dendritic cells alters metabolism and cytokine release and initiates tolerizing T cell programming

D. Molenaar, Y. van Kooyk, S. Bruijns, 2021, Immunotherapy advances.

Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells

T. Sparwasser, J. Ilarregui, P. Crocker, 2016, Proceedings of the National Academy of Sciences.

Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses

T. D. de Gruijl, Y. van Kooyk, S. Bruijns, 2020, Frontiers in Immunology.

CNS myelin induces regulatory functions of DC-SIGN–expressing, antigen-presenting cells via cognate interaction with MOG

Y. Kooyk, T. O’Toole, J. Ilarregui, 2014, The Journal of experimental medicine.

Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells.

K. Nazmi, J. Garcia-Vallejo, Y. van Kooyk, 2013, Molecular immunology.

Activation of CD8+ T Cell Responses after Melanoma Antigen Targeting to CD169+ Antigen Presenting Cells in Mice and Humans

Y. van Kooyk, J. Stöckl, M. Ambrosini, 2019, Cancers.

In situ Delivery of Tumor Antigen- and Adjuvant-Loaded Liposomes Boosts Antigen-Specific T-Cell Responses by Human Dermal Dendritic Cells.

G. Storm, Y. van Kooyk, S. Bruijns, 2015, The Journal of investigative dermatology.

Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomes

G. Kazemier, T. D. de Gruijl, G. Storm, 2020, Proceedings of the National Academy of Sciences.

MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses.

G. Storm, J. Garcia-Vallejo, Y. van Kooyk, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Activation of CD 8 + T Cell Responses after Melanoma Antigen Targeting to CD 169 + Antigen Presenting Cells in Mice and Humans

Y. Kooyk, J. Stöckl, M. Ambrosini, 2019 .

Palmitoylated antigens for the induction of anti-tumor CD8+ T cells and enhanced tumor recognition

T. D. de Gruijl, J. Garcia-Vallejo, Y. van Kooyk, 2021, Molecular therapy oncolytics.

Subcutaneous immunotherapy using modified Phl p5a‐derived peptides efficiently alleviates allergic asthma in mice

M. Nawijn, Y. Kooyk, A. Petersen, 2019, Allergy.

A convenient preparation of 3-isopropyl-1-methylcyclopentylmethanol and 1-isopropyl-3-methylcyclopentylmethanol via Favorskii rearrangement

S. Benetti, G. Pollini, V. Zanirato, 2009 .

Controlled release of a model vaccine by nanoporous ceramic microneedle arrays.

Regina Luttge, Y. Kooyk, R. Luttge, 2015, International journal of pharmaceutics.

Online nanoliquid chromatography-mass spectrometry and nanofluorescence detection for high-resolution quantitative N-glycan analysis.

P. Parren, Y. van Kooyk, P. V. van Berkel, 2012, Analytical biochemistry.

Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.

T. Geijtenbeek, N. Koning, J. Garcia-Vallejo, 2013, International immunology.

Controlled release of a model vaccine by nanoporous ceramic microneedle arrays.

Y. Kooyk, R. Luttge, S. Engels, 2015, International journal of pharmaceutics.

Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunity.

M. Ambrosini, A. D. de Haas, K. Olesek, 2024, International journal of pharmaceutics.